GlassScriptPhysician profile
Timothy A Holt
NPI 1689723868
$477,920.47
in general payments reported to CMS, 2019-2025
36 companies · $54K in 2025
The $54K reported for 2025 was more than what 88% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $24K · 2021: $69K · 2022: $79K · 2023: $84K · 2024: $96K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $193K · Travel and Lodging: $30K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $192,950.00 |
| Travel and Lodging | $29,814.64 |
| Food and Beverage | $11,138.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $435,665.94 | 2019-2025 | |
| Medtronic, INC. | $8,821.91 | 2021-2025 | Cd Horizon Spinal System, Unid_pass, Mazor X System |
| Kuros Biosciences USA, INC | $8,324.25 | 2019-2025 | Magnetos |
| Nuvasive, INC. | $5,129.24 | 2019-2023 | Acp, Attrax, Formagraft |
| Medtronic USA, INC. | $4,350.74 | 2019-2020 | |
| Cerapedics INC. | $3,934.87 | 2021 | |
| Globus Medical, INC. | $2,261.69 | 2024-2025 | Xlif, Modulus, Elsa |
| Boston Scientific Corporation | $1,824.90 | 2019-2024 | Artisan |
| Integrity Implants INC. | $1,551.00 | 2021 | |
| Spineology INC. | $1,188.09 | 2022-2023 | Optimesh Expandable Interbody Fusion System |
| Life Spine, INC. | $1,047.49 | 2021 | |
| Surgalign Spine Technologies, INC. | $724.77 | 2019-2020 | |
| Providence Medical Technology, INC. | $648.40 | 2019-2025 | |
| Abbott Laboratories | $548.84 | 2022-2025 | Proclaim, Eterna |
| Mirus, LLC | $432.06 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $308.28 | 2022-2025 | |
| Depuy Synthes Sales INC. | $168.45 | 2020-2022 | |
| Stryker Corporation | $122.82 | 2023-2024 | Spinejack, Stryker |
| Orthofix Medical, INC. | $120.27 | 2019-2022 | |
| 4web, INC. | $117.16 | 2024 | Spine Truss System |
| Bioventus LLC | $96.24 | 2023-2024 | Bonescalpel & Sonicone (O.R.) |
| Abbvie INC. | $86.14 | 2021-2025 | |
| Carlsmed, INC. | $78.85 | 2022-2024 | Aprevo |
| Radius Health, INC. | $52.28 | 2021 | |
| Neurocrine Biosciences, INC. | $42.77 | 2025 | |
| Acadia Pharmaceuticals INC | $40.76 | 2025 | Nuplazid |
| Arteriocyte Medical Systems, INC. | $37.74 | 2025 | Magellan |
| Medical Device Business Services, INC. | $33.44 | 2022 | |
| Ucb, INC. | $23.21 | 2025 | Briviact |
| Arbor Pharmaceuticals, INC. | $21.25 | 2021 | |
| Kci USA, INC. | $20.95 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.68 | 2025 | Ultomiris |
| Convatec INC. | $19.88 | 2019 | |
| Ethicon US, LLC | $19.78 | 2020 | |
| Janssen Biotech, INC. | $18.84 | 2025 | |
| Baxter Healthcare | $16.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.